| Vonda Gilgen Calcutt, MD | |
|
16 Northside Dr, Walterboro, SC 29488-7219 | |
| (843) 538-8585 | |
| (843) 538-4777 |
| Full Name | Vonda Gilgen Calcutt |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 33 Years |
| Location | 16 Northside Dr, Walterboro, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477591162 | NPI | - | NPPES |
| 42D0952228 | Other | SC | RAILROAD MEDICARE |
| 200231 | Medicaid | SC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaufort County Memorial Hospital | Beaufort, SC | Hospital |
| Colleton Medical Center | Walterboro, SC | Hospital |
| Hampton Regional Medical Center | Varnville, SC | Hospital |
| Hilton Head Regional Medical Center | Hilton head island, SC | Hospital |
| Allendale County Hospital | Fairfax, SC | Hospital |
| Entity Name | Lowcountry Center For Diabetes & Endocrinology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215106794 PECOS PAC ID: 6406085208 Enrollment ID: O20140127000481 |
News Archive
Miami resident Hans Lobato pleaded guilty today to engaging in a fraudulent medical testing scheme, announced the Departments of Justice and Health and Human Services (HHS).
One drug attacks tumor cells directly, the other treats the immune system by taking the brakes off T cell response.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).
This week, a team of researchers and partners published findings that show a startling gap in the evidence about treatment for mental health and substance use challenges for people with Fetal Alcohol Spectrum Disorder.
Providing healthier food choices for our nation's schoolchildren is a hot-button issue in Michelle Obama's Let's Move campaign. And a team of researchers from Cornell University have recently identified one simple solution to help schools serve more fresh vegetables and salad items.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vonda Gilgen Calcutt, MD 16 Northside Dr, Walterboro, SC 29488-7219 Ph: (843) 538-8585 | Vonda Gilgen Calcutt, MD 16 Northside Dr, Walterboro, SC 29488-7219 Ph: (843) 538-8585 |
News Archive
Miami resident Hans Lobato pleaded guilty today to engaging in a fraudulent medical testing scheme, announced the Departments of Justice and Health and Human Services (HHS).
One drug attacks tumor cells directly, the other treats the immune system by taking the brakes off T cell response.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).
This week, a team of researchers and partners published findings that show a startling gap in the evidence about treatment for mental health and substance use challenges for people with Fetal Alcohol Spectrum Disorder.
Providing healthier food choices for our nation's schoolchildren is a hot-button issue in Michelle Obama's Let's Move campaign. And a team of researchers from Cornell University have recently identified one simple solution to help schools serve more fresh vegetables and salad items.
› Verified 4 days ago
Dr. Michael L Blubaugh, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 461 Spruce St, Walterboro, SC 29488 Phone: 843-549-4335 Fax: 843-782-3070 | |
Leo J Jesion, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 501 Robertson Blvd, Walterboro, SC 29488 Phone: 843-782-2767 Fax: 843-549-6867 | |
Ashley Elaine Ward, FNP Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 300 Ruby St, Walterboro, SC 29488 Phone: 843-549-5599 Fax: 843-549-5512 | |
Dr. Sanjay Kumar, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 461 Spruce St, Walterboro, SC 29488 Phone: 843-549-4335 Fax: 843-549-6502 | |
Dr. Phillip Jeffrey Bower, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 302 Medical Park Dr, Suite 207, Walterboro, SC 29488 Phone: 843-782-2788 Fax: 843-782-2797 | |
Dr. Vijaysai Veerapaneni, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 501 Robertson Blvd, Walterboro, SC 29488 Phone: 843-782-2000 | |
Dr. Barry Lorenzo Lee, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 811 Carn St, Walterboro, SC 29488 Phone: 843-549-1998 Fax: 843-542-2918 |